Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent users

Neuropharmacology

Volumn 85, Issue , 2014, Pages 493-498

  Kalechstein, Ari D ^a   Mahoney III, James J ^a   Verrico, Christopher D ^a   De La Garza II, Richard ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Information processing speed; Methamphetamine; Varenicline

Indexed keywords

METHAMPHETAMINE; PLACEBO; VARENICLINE; BENZAZEPINE DERIVATIVE; NICOTINIC AGENT; NOOTROPIC AGENT; QUINOXALINE DERIVATIVE;

ADULT; ARTICLE; ATTENTION; AUDITORY STIMULATION; CAUCASIAN; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; EPISODIC MEMORY; FEMALE; HUMAN; INFORMATION PROCESSING SPEED; LOW DRUG DOSE; MALE; METHAMPHETAMINE DEPENDENCE; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPONSE TIME; SEX RATIO; SHORT COURSE THERAPY; STIMULUS RESPONSE; TREATMENT DURATION; VISUAL STIMULATION; WORKING MEMORY; DRUG ABUSE; DRUG EFFECTS; DRUG THERAPY; HEARING; PHOTOSTIMULATION; PSYCHOLOGY; REACTION TIME; TIME; TREATMENT OUTCOME; VISION;

ACOUSTIC STIMULATION; ADULT; AMPHETAMINE-RELATED DISORDERS; AUDITORY PERCEPTION; BENZAZEPINES; FEMALE; HUMANS; MALE; METHAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; NICOTINIC AGONISTS; NOOTROPIC AGENTS; PHOTIC STIMULATION; QUINOXALINES; REACTION TIME; TIME FACTORS; TREATMENT OUTCOME; VISUAL PERCEPTION;

EID: 84903822879     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.05.045     Document Type: Article

References (53)

1. E. Aharonovich, P.C. Amrhein, A. Bisaga, E.V. Nunes, and D.S. Hasin Cognition, commitment language, and behavioral change among cocaine-dependent patients Psychol. Addict. Behav. 22 2008 557 562
2. E. Aharonovich, D.S. Hasin, A.C. Brooks, X. Liu, A. Bisaga, and E.V. Nunes Cognitive deficits predict low treatment retention in cocaine dependent patients Drug Alcohol Depend. 81 2006 313 322 (Pubitemid 43152458)
3. E. Aharonovich, E. Nunes, and D. Hasin Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment Drug Alcohol Depend. 71 2003 207 211 (Pubitemid 37289030)
4. W.B. Barr Neuropsychological testing of high school athletes. Preliminary norms and test-retest indices Arch. Clin. Neuropsychol. 18 2003 91 101 (Pubitemid 36120397)
5. M.E. Bates, S.C. Bowden, and D. Barry Neurocognitive impairment associated with alcohol use disorders: implications for treatment Exp. Clin. Psychopharmacol. 10 2002 193 212 (Pubitemid 34919929)
6. M.E. Bates, J.F. Buckman, and T.T. Nguyen A role for cognitive rehabilitation in increasing the effectiveness of treatment for alcohol use disorders Neuropsychol. Rev. 23 2013 27 47
7. R.H. Benedict, and D.J. Zgaljardic Practice effects during repeated administrations of memory tests with and without alternate forms J. Clin. Exp. Neuropsychol. 20 1998 339 352 (Pubitemid 28539554)
8. J. Brandt Hopkins Verbal Learning Test - Revised (HVLT-R) 2005 Psychological Assessment Resources, Inc. Lutz, FL
9. M. Brensilver, K.G. Heinzerling, A.N. Swanson, D. Telesca, B.A. Furst, and S.J. Shoptaw Cigarette smoking as a target for potentiating outcomes for methamphetamine abuse treatment Drug Alcohol Rev. 32 2013 96 99
10. K. Cahill, L.F. Stead, and T. Lancaster Nicotine receptor partial agonists for smoking cessation Cochrane Database Syst. Rev. 2011 CD006103
11. M. Cherner, P. Suarez, C. Casey, R. Deiss, S. Letendre, T. Marcotte, F. Vaida, J.H. Atkinson, I. Grant, and R.K. Heaton Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults Drug Alcohol Depend. 106 2010 154 163
12. P.M. Cinciripini, J.D. Robinson, M. Karam-Hage, J.A. Minnix, C. Lam, F. Versace, V.L. Brown, J.M. Engelmann, and D.W. Wetter Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal JAMA Psychiatry 70 2013 522 533
13. J. Cohen Eta-squared and partial eta-squared in fixed factor ANOVA designs Educ. Psychol. Meas. 33 1973 107 112
14. J. Cohen Statistical Power Analysis for the Behavioral Sciences 1988 Erlbaum Hillsdale, NJ
15. C.K. Conners Conners' Continuous Performance Test - II (CPT-II) 2002 Multi-Health Systems, Inc
16. C.C. Cruickshank, and K.R. Dyer A review of the clinical pharmacology of methamphetamine Addiction 104 2009 1085 1099
17. R. De La Garza 2nd, T.F. Newton, C.N. Haile, J.H. Yoon, C.S. Nerumalla, J.J. Mahoney 3rd, and A. Aziziyeh Rivastigmine reduces "Likely to use methamphetamine" in methamphetamine-dependent volunteers Prog. Neuropsychopharmacol. Biol. Psychiatry 37 2012 141 146
18. A.C. Dean, S.M. Groman, A.M. Morales, and E.D. London An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans Neuropsychopharmacology 38 2013 259 274
19. A.C. Dean, G. Hellemann, C.A. Sugar, and E.D. London Educational attainment is not a good proxy for cognitive function in methamphetamine dependence Drug Alcohol Depend. 123 2012 249 254
20. A.C. Dean, R.J. Sevak, J.R. Monterosso, G. Hellemann, C.A. Sugar, and E.D. London Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans J. Stud. Alcohol Drugs 72 2011 943 953
21. H.M. Faessel, R.S. Obach, H. Rollema, P. Ravva, K.E. Williams, and A.H. Burstein A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation Clin. Pharmacokinet. 12 2010 799 816
22. D.G. Ghahremani, G. Tabibnia, J. Monterosso, G. Hellemann, R.A. Poldrack, and E.D. London Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals Neuropsychopharmacology 5 2011 950 959
23. D.C. Gooding, S. Burroughs, and N.N. Boutros Attentional deficits in cocaine-dependent patients: converging behavioral and electrophysiological evidence Psychiatry Res. 160 2008 145 154
24. R.W. Gould, P.W. Czoty, S.H. Nader, and M.A. Nader Effects of varenicline on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys J. Pharmacol. Exp. Ther. 339 2011 678 686
25. C.L. Hart, C.B. Marvin, R. Silver, and E.E. Smith Is cognitive functioning impaired in methamphetamine users? A critical review Neuropsychopharmacology 37 2012 586 608
26. S.M. Jaeggi, M. Buschkuehl, J. Jonides, and W.J. Perrig Improving fluid intelligence with training on working memory Proc. Natl. Acad. Sci. U. S. A. 105 2008 6829 6833 (Pubitemid 351754490)
27. A.D. Kalechstein, R. De La Garza 2nd, and T.F. Newton Modafinil administration improves working memory in methamphetamine-dependent individuals who demonstrate baseline impairment Am. J. Addict. 19 2010 340 344
28. A.D. Kalechstein, J.J. Mahoney 3rd, J.H. Yoon, R. Bennett, and R. De la Garza 2nd Modafinil, but not escitalopram, improves working memory and sustained attention in long-term, high-dose cocaine users Neuropharmacology 64 2013 472 478
29. A.D. Kalechstein, T.F. Newton, and W.G. van Gorp Neurocognitive functioning is associated with employment status: a quantitative review J. Clin. Exp. Neuropsychol. 25 2003 1186 1191 (Pubitemid 37421783)
30. G. Keppel Design and Analysis: a Researcher's Handbook 1982 Prentice Hall, Inc. Englewood Cliffs, New Jersey
31. R.Z. Litten, M.L. Ryan, J.B. Fertig, D.E. Falk, B. Johnson, K.E. Dunn, A.I. Green, H.M. Pettinati, D.A. Ciraulo, O. Sarid-Segal, K. Kampman, M.F. Brunette, E.C. Strain, N.A. Tiouririne, J. Ransom, C. Scott, and R. Stout A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence J. Addict. Med. 7 2013 277 286
32. J. Loughead, R. Ray, E.P. Wileyto, K. Ruparel, P. Sanborn, S. Siegel, R.C. Gur, and C. Lerman Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers Biol. Psychiatry 67 2010 715 721
33. J.J. Mahoney 3rd, B.J. Jackson, A.D. Kalechstein, R. De la Garza 2nd, and T.F. Newton Acute, low-dose methamphetamine administration improves attention/information processing speed and working memory in methamphetamine-dependent individuals displaying poorer cognitive performance at baseline Prog. Neuropsychopharmacol. Biol. Psychiatry 35 2011 459 465
34. J.J. Mahoney 3rd, A.D. Kalechstein, C.D. Verrico, N.M. Arnoudse, B.A. Shapiro, and R. De La Garza 2nd Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteers Prog. Neuropsychopharmacol. Biol. Psychiatry 50 2014 137 142
35. J.M. Mitchell, C.H. Teague, A.S. Kayser, S.E. Bartlett, and H.L. Fields Varenicline decreases alcohol consumption in heavy-drinking smokers Psychopharmacol. (Berl) 223 2012 299 306
36. T.F. Newton, M.S. Reid, R. De La Garza, J.J. Mahoney, A. Abad, R. Condos, J. Palamar, P.N. Halkitis, J. Mojisak, A. Anderson, S.H. Li, and A. Elkashef Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers Int. J. Neuropsychopharmacol. 11 2008 1037 1045
37. F. Patterson, C. Jepson, A.A. Strasser, J. Loughead, K.A. Perkins, R.C. Gur, J.M. Frey, S. Siegel, and C. Lerman Varenicline improves mood and cognition during smoking abstinence Biol. Psychiatry 65 2009 144 149
38. Pfizer Varenicline [Material Safety Data Sheet] 2008
39. J.G. Plebani, K.G. Lynch, Q. Yu, H.M. Pettinati, C.P. O'Brien, and K.M. Kampman Results of an initial clinical trial of varenicline for the treatment of cocaine dependence Drug Alcohol Depend. 121 2012 163 166
40. H. Rollema, M. Hajos, P.A. Seymour, R. Kozak, M.J. Majchrzak, V. Guanowsky, W.E. Horner, D.S. Chapin, W.E. Hoffmann, D.E. Johnson, S. McLean, J. Freeman, and K.E. Williams Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition Biochem. Pharmacol. 78 2009 813 824
41. M.R. Schoenberg, J.G. Scott, K. Duff, and R.L. Adams Estimation of WAIS-III intelligence from combined performance and demographic variables: development of the OPIE-3 Clin. Neuropsychol. 16 2002 426 437
42. J.C. Shim, D.U. Jung, S.S. Jung, Y.S. Seo, D.M. Cho, J.H. Lee, S.W. Lee, B.G. Kong, J.W. Kang, M.K. Oh, S.D. Kim, R.P. McMahon, and D.L. Kelly Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial Neuropsychopharmacology 37 2012 660 668
43. M. Sofuoglu Cognitive enhancement as a pharmacotherapy target for stimulant addiction Addiction 105 2010 38 48
44. M. Sofuoglu, E.E. DeVito, A.J. Waters, and K.M. Carroll Cognitive enhancement as a treatment for drug addictions Neuropharmacology 64 2013 452 463
45. E. Strauss, E. Sherman, and O. Spreen A Compendium of Neuropsychological Tests 2006 Oxford University Press New York, New York
46. Substance Abuse and Mental Health Services Administration Results from the 2011 National Survey on Drug Use and Health Summary of National Findings. NSDUH Series H-44, HHS Publication No. (SMA) 2012 Substance Abuse and Mental Health Services Administration Rockville, MD 12 4713
47. D. Tziortzis, J.J. Mahoney 3rd, A.D. Kalechstein, T.F. Newton, and R. De La Garza 2nd The relationship between impulsivity and craving in cocaine- and methamphetamine-dependent volunteers Pharmacol. Biochem. Behav. 98 2011 196 202
48. A. Verdejo-Garcia, R. Vilar-Lopez, M. Perez-Garcia, K. Podell, and E. Goldberg Altered adaptive but not veridical decision-making in substance dependent individuals J. Int. Neuropsychol. Soc. 12 2006 90 99 (Pubitemid 43379955)
49. C.D. Verrico, J.J. Mahoney, D.G. Thompson-Lake, R.S. Bennett, T.F. Newton, and R. De La Garza 2nd Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine- dependent volunteers Int. J. Neuropsychopharmacol. 17 2014 223 233
50. D. Wechsler Wechsler Adult Intelligence Scale - III 2007 The Psychological Corporation San Antonio, TX
51. T.M. Winhusen, B. Adinoff, D.F. Lewis, G.S. Brigham, J.G. Gardin 2nd, S.C. Sonne, J. Theobald, and U. Ghitza A tale of two stimulants: mentholated cigarettes may play a role in cocaine, but not methamphetamine, dependence Drug Alcohol Depend. 133 2013 845 851
52. T.M. Winhusen, F. Kropp, J. Theobald, and D.F. Lewis Achieving smoking abstinence is associated with decreased cocaine use in cocaine-dependent patients receiving smoking-cessation treatment Drug Alcohol Depend. 134 2014 391 395
53. T.M. Winhusen, E.C. Somoza, D.F. Lewis, F.B. Kropp, V.E. Horigian, and B. Adinoff Frontal systems deficits in stimulant-dependent patients: evidence of pre-illness dysfunction and relationship to treatment response Drug Alcohol Depend. 127 2013 94 100